The MHRA and the Regulatory Innovation Office (RIO) invite organisations to share their views on the use of artificial intelligence (AI) in medicines development.
UK MHRA · September 22, 2026
Beyond ADMET: AI for medicines safety - survey
MHRA and RIO invite stakeholder input on artificial intelligence use in medicines development and safety.
Published by UK MHRA. HealthSignal links to the original document; the summary above is extracted from the source text.